Could a liquid biopsy test lead to earlier diagnoses for numerous cancer types?

Study shows it would lead to increases in stages I–III diagnoses and a large decrease in stage IV diagnoses.

2025-11-10

(Press-News.org) Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing (multi-cancer early detection testing) could substantially reduce late-stage cancer diagnoses, allowing patients to receive treatment at earlier cancer stages, which are more likely to respond to interventions. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Currently, routine screening is only recommended for four types of cancer, leaving approximately 70% of new cancer cases to be detected only after symptoms appear, often at an advanced stage when survival rates are lower. Multi-cancer early detection tests offer a revolutionary approach by screening for multiple cancer types simultaneously from a single blood draw.

To evaluate the impact of one such test, Cancerguard, investigators used epidemiological data from the Surveillance, Epidemiology, and End Results database and developed a simulation model of 14 cancer types, which account for nearly 80% of cancer incidence and mortality. The researchers simulated 10-year disease progression for 5 million US adults aged 50–84 years and assessed the effects of incorporating an annual blood-based multi-cancer early detection test into standard care.

The model estimated that over 10 years, supplemental multi-cancer early detection testing would lead to a 10% increase in stage I diagnoses, a 20% increase in stage II diagnoses, a 30% increase in stage III diagnoses, and a 45% decrease in stage IV diagnoses, relative to standard care. The largest absolute reductions in stage IV diagnoses were in lung, colorectal, and pancreatic cancers. The largest relative reductions were in cervical, liver, and colorectal cancers.

“Our analysis shows that multi-cancer blood tests could be a game changer for cancer control,” said Jagpreet Chhatwal, PhD, the study’s lead author and Director of the Institute for Technology Assessment at Massachusetts General Hospital and Harvard Medical School. “By detecting cancers earlier—before they spread—these tests could potentially improve survival and reduce the personal and economic burden of cancer.”

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com

Full Citation:
“The Impact of Multi-Cancer Early Detection Tests on Cancer Stage Shift: A 10-Year Microsimulation Model.” Jagpreet Chhatwal, Jade Xiao, Andrew K. ElHabr, Christopher Tyson, Xiting Cao, Sana Raoof, A. Mark Fendrick, A. Burak Ozbay, Paul Limburg, Tomasz M. Beer, Andrew Briggs, and Ashish Deshmukh. CANCER; Published Online: November 10, 2025 (DOI: 10.1002/cncr.70075).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.70075

Author Contact: Elizabeth Murphy of the Massachusetts General Hospital, at emurphy@mgb.org

About the Journal   
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on X @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley    
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

END

ELSE PRESS RELEASES FROM THIS DATE:

Link found between chronic fatigue and abnormal breathing could lead to new treatments

2025-11-10

Chronic fatigue syndrome leaves patients exhausted and struggling with brain fog — and it typically gets worse after mental or physical exercise, a phenomenon called post-exertional malaise. Now scientists investigating shortness of breath in chronic fatigue patients have discovered that they are highly likely to experience dysfunctional breathing, which could be caused by dysautonomia, abnormal control of innervation to blood vessels and muscles. Targeting treatments towards these breathing problems ...

Beauty and fear

2025-11-10

New Zealand — particularly the South Island/Te Waipounamu — is one of the most seismically active regions in the world. For this reason, the country has acknowledged the importance of building awareness and preparedness. In this kind of disaster communication, emotions — whether conscious or not — play a crucial role. Caroline Rowe, researcher at the Centre for Sustainability Research, University of Otago, New Zealand, explored this dimension, showing how risk communication can balance fear and anxiety with positive emotions such as fascination and confidence, using vivid imagery, ...

Between solstices and equinoxes

2025-11-10

“People tend to joke about mood swings, saying ‘my mood swings throughout the day, I’m already a bit bipolar,’ or joke with each other saying ‘everything is bipolar.’ And it’s not quite like that, as bipolar disorder has a biological component.” This is one of the statements featured in a short trailer on YouTube about bipolar disorder. The video is connected to the play Oxímoro, entre Solstícios e Equinócios (Oxymoron, Between Solstices and Equinoxes) by Marionet, a Portuguese theatre company that brings scientific research topics to the stage. The play was developed through an in-depth collaboration with doctors, ...

New study gives people with eczema freedom to choose how often to bathe

2025-11-10

A major study has found that people with eczema are able to bathe either daily or weekly, without any impact to their symptoms. The findings of the new study, which are published in the British Journal of Dermatology, are great news for people living with eczema, as it will mean they will have the freedom to choose how often to bathe without fear it will worsen their symptoms. People with eczema often have questions about how best to bathe including how often to have a bath or shower. The ‘Eczema Bathing study’, was prioritised and developed by people living with eczema, in partnership with researchers from ...

Children’s dental health still very poor despite interventions

2025-11-10

Children's access to NHS dentists and rates of tooth decay remain very poor despite improvements from national government interventions, oral health experts say. Analysis of the latest government data by the Child of the North initiative gives cause for cautious optimism, they say, but the schemes need to be scaled up and strengthened to meet the needs of young people across the country. The latest update, titled Improving Children’s Oral Health Update: Integrated Health and Education Solutions, is the seventh to be released ...

Hospital patients who feel short of breath are six times more likely to die

2025-11-10

The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published today (Monday) in ERJ Open Research [1]. Patients who were in pain were not more likely to die. The study of nearly 10,000 people suggests that asking patients if they are feeling short of breath could help doctors and nurses to focus care on those who need it most. The study is the first of its kind and was led by Associate Professor Robert Banzett from Beth Israel Deaconess Medical Center, Harvard Medical School, ...

Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children

2025-11-10

Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ today, in direct response to recent announcements around the safety of using paracetamol in pregnancy. The researchers say confidence in the findings of existing evidence reviews and studies on this topic is low to critically low, and suggest that any apparent effect seen in previous studies may be driven by shared genetic and environmental factors within families. Regulatory bodies, clinicians, pregnant women, parents, and those affected by autism and ADHD should be informed ...

Should kids be screened for high cholesterol genes?

2025-11-09

Nov. 9, 2025--In the United States, one in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels from birth. If high cholesterol isn’t lowered early, people with this genetic condition, called familial hypercholesterolemia (FH), have a high risk of having a heart attack or stroke as early as their 30s or 40s. But only about 1 in 10 of people living with FH (1.5 million Americans) is aware of their condition. A new modeling study conducted by researchers at Columbia and Harvard Universities finds ...

Weight loss drugs don’t increase the risk of pancreatitis or adverse cardiac events in patients with high triglycerides

2025-11-09

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events. Since the first GLP-1 receptor agonists (GLP1RAs), more commonly known now as weight loss drugs, were approved in 2005, some clinicians have been hesitant to prescribe them to people who have very high triglycerides. That’s because these patients are typically at high risk of pancreatitis, and the drugs interact with the pancreas. In the new study, Intermountain researchers found that ...

Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function

2025-11-09

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors with preserved cardiac function enrolled in five global clinical trials. The study concludes that beta-blockers offer no clinical benefit for this patient group, which today represents the majority of infarction survivors. The study was made possible by close collaboration between CNIC researchers and the ...

LAST 30 PRESS RELEASES: